Rocaltrol 0,25 µg/ 0,50 µg Capsules
PDF Leaflet Revision Date: 29 April 2005
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct treatment for post-menopausal osteoporosis and renal bone disease.
Dosage (summary)
0.25 u03bcg twice daily for osteoporosis; adjust based on serum calcium.
Onset of Action / Duration
Onset: 2-6 hours, Duration: 5-8 hours
Special Populations
- Renal impairment
- Elderly patients
Pregnancy & Breastfeeding
Use in pregnancy only if benefits outweigh risks; avoid breastfeeding.
Key Drug Interactions
- Thiazides increase hypercalcaemia risk
- Digitalis may cause dysrhythmias
- Avoid magnesium-containing antacids
Contraindications
- Hypercalcaemia
- Hypersensitivity to calcitriol
Common side effects
- Hypercalcaemia
- Decreased appetite
- Nausea
- Headache
Counselling Points
- Adhere to prescribed diet
- Recognize hypercalcaemia symptoms
- Monitor fluid intake
Serious warnings
- Monitor serum calcium and phosphate levels
- Risk of hypercalcaemia with dietary changes
Important Disclaimer
The Rocaltrol 0,25 µg/ 0,50 µg Capsules professional information leaflet below is the property of Pharmaco Distribution and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
